[HTML][HTML] Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors …

Y Tsutani, Y Miyata, H Nakayama, S Okumura… - Annals of oncology, 2013 - Elsevier
Background To better describe clinical T descriptors using solid tumor size (the maximum
dimension of the solid component of the tumor) on high-resolution computed tomography …

[HTML][HTML] Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma

YH Chen, TF Wang, SC Chu, CB Lin, LY Wang… - PLoS …, 2020 - journals.plos.org
Background To investigate the survival prognostic value of the radiomic features of 18F-FDG
PET in patients who had EGFR (epidermal growth factor receptor) mutated lung …

Absence of clinical benefit of FDG PET-CT in staging T1 part-solid lung adenocarcinoma

D Pencharz, S Modi, S Bandyopadhyay, U Alhun… - Clinical Radiology, 2022 - Elsevier
AIM To assess the rates of nodal and metastatic disease and change in management when
staging part-solid T1 lung adenocarcinomas using integrated 2-[18 F]-fluoro-2-deoxy-d …

[HTML][HTML] Prognostic impact of an integrative analysis of [18F]FDG PET parameters and infiltrating immune cell scores in lung adenocarcinoma

J Choi, A Sarker, H Choi, DS Lee, HJ Im - EJNMMI research, 2022 - Springer
Background High levels of 18F-fluorodeoxyglucose (18F-FDG) tumor uptake are associated
with worse prognosis in patients with non-small cell lung cancer (NSCLC). Meanwhile, high …

Positron emission tomography for predicting recurrence in stage I lung adenocarcinoma: standardized uptake value corrected by mean liver standardized uptake …

S Shiono, M Abiko, T Okazaki, M Chiba… - European journal of …, 2011 - academic.oup.com
Abstract Objective: F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) has
become an important staging tool for patients with lung cancer, and determination of the …

Combination of clinical factors and PET/CT features can predict positive PD-L1 for patients with lung adenocarcinoma: a novel approach based on 18F-FDG PET/CT …

J Xiao - 2020 - Soc Nuclear Med
1332 Objectives: To retrospectively evaluate the diagnostic accuracy and predictive ability of
18 F-FDG PET/CT in the status of PD-L1 expression of adenocarcinoma lung cancer …

Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer

DP Dunagan, R Chin Jr, TW Mc Cain, LD Case… - Chest, 2001 - Elsevier
Background Positron emission tomography (PET) scanningis used increasingly to detect
and stage lung cancer, but the testperformance characteristics and relationship of PET to …

Maximum standardized uptake value on positron emission tomography is associated with more advanced disease and high-risk features in lung adenocarcinoma

T Koike, N Sato, Y Hosoda, M Tazawa, T Goto… - Seminars in Thoracic …, 2022 - Elsevier
18 F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG-
PET/CT) has been widely used for preoperative staging of lung adenocarcinomas. The aim …

[HTML][HTML] FDG-PET/CT tumor to liver SUV ratio (TLR), tumor SUVmax, and tumor size: can this help in differentiating squamous cell carcinoma from adenocarcinoma of …

AMA Salem, LH Hussein, AM Osman - Egyptian Journal of Radiology and …, 2022 - Springer
Background PET/CT plays an essential role in the diagnosis, staging, and follow-up of lung
cancer. We aimed to assess the ability of PET/CT to differentiate between adenocarcinomas …

Radiomic analysis of pre-treatment FDG PET prognosticates survival in non-small cell lung cancer

C Cung, W Wong, R Martin, IH Shon - 2020 - Soc Nuclear Med
277 Objectives: Intratumour heterogeneity, quantified by radiomic analysis of 18F-
fluorodeoxyglucose positron emission tomography (FDG PET), has shown associations with …